Structure-Based Drug Design, Cambridge, MA, USA
Event Apr 28
The past year has seen a steady and exciting growth of novel inhibitors identified through computational analysis of target structure. A combination of more structures, advances in homology modeling, better docking and scoring tools, fragment-based methods, and advances in virtual screening has been fundamental in this progress. De novo design of small molecules is clearly becoming a valuable and integral part of the drug discovery, and the results are emerging. Structure Based Drug Design hears case studies of successful generation of leads from structure-based design and medicinal chemistry efforts and learn how to apply these approaches to make your own discovery and development more efficient and productive.